University of Colorado Division of Hematology | VuMedi

University of Colorado Division of Hematology

University of Colorado Division of Hematology

University of Colorado Division of Hematology

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

By University of Colorado Division of Hematology FEATURING Manali Kamdar

By University of Colorado Division of Hematology FEATURING Manali Kamdar

251 views

April 8, 2024

FDA Approved Bispecific Antibodies for B-cell Lymphoma

00:00

Long-term Follow-up of Glofitamab in Treatment

02:45

Mosunetuzumab & Polatuzumab for Refractory Large B-Cell Lymphoma

04:37

Comparing CAR-T & CD20 Bispecific T-Cell Engagers

07:47

Frontline Treatment with Axi-cel & Glofitamab

10:39

Indolent Follicular Lymphoma Treatment Updates

13:48

Managing High-risk Mantle Cell Lymphoma

21:16

CLL Treatment Advances & Richter's Transformation Data

28:05

Comments 0

Login to view comments. Click here to Login